Photo taken from Jill Lykon/X
Dec 14, 2023, 12:53
Jill Lykon: We presented our data on toci pre-med prior to teclistamab step up dose
Jill Lykon, Clinical Oncology Pharmacy Manager at the University of Miami Health System, posted on X/Twitter:
“To close out ASH23 we presented our data on toci pre-med prior to teclistamab step up dose 1. Low CRS (13%), no repeated doses of toci. Still need pharm-eco and response rate data to make this SOC.”
Source: Jill Lykon/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 19, 2025, 21:04
Apr 19, 2025, 20:48
Apr 19, 2025, 20:25
Apr 19, 2025, 19:36
Apr 19, 2025, 19:17
Apr 19, 2025, 19:01
Apr 19, 2025, 18:42
Apr 19, 2025, 18:29